AN2 Therapeutics
ANTX
ANTX
37 hedge funds and large institutions have $19.5M invested in AN2 Therapeutics in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
3% less capital invested
Capital invested by funds: $20.1M → $19.5M (-$546K)
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
Holders
37
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$935K | |
| 2 | +$87.5K | |
| 3 | +$85.6K | |
| 4 |
RC
Rangeley Capital
New Canaan,
Connecticut
|
+$68K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$35.5K |
Top Sellers
| 1 | -$287K | |
| 2 | -$271K | |
| 3 | -$217K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$139K |
| 5 |
MAM
Marquette Asset Management
Minneapolis,
Minnesota
|
-$115K |
